Altered hepatic inflammatory response in the offspring following prenatal LPS exposure.

Oliver Surriga,Andres Ortega,Viren Jadeja,Alexander Bellafronte,Natalie Lasala,Heping Zhou
DOI: https://doi.org/10.1016/j.imlet.2009.02.009
IF: 4.23
2009-01-01
Immunology Letters
Abstract:There is increasing evidence that maternal immune activation has a significant impact on the offspring's immune function. In this study, we examined the effects of maternal immune activation on the offspring's hepatic inflammatory response. We treated pregnant rats with 500μg/kg LPS or saline on day 18 of pregnancy, subsequently stimulated the offspring with 250μg/kg LPS or saline at postnatal day (P) 21, and then examined the expression of LPS cell surface receptors, namely toll-like receptor (TLR)-4 and CD14, and cytokines, namely tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6, as well as the activation of key intracellular mediators of the TLR-4 signaling cascade, namely p38 MAPK and p42/44 MAPK, in the offspring liver. We found that LPS-induced mRNA expression of IL-6 in the pups born to LPS-treated dams was significantly diminished compared with that in the pups born to saline-treated dams. Furthermore, maternal immune activation attenuated LPS-induced phosphorylation of p42/44 MAPK compared with the control pups without significantly affecting the phosphorylation of p38 MAPK. The correlation between the level of IL-6 expression and that of phosphorylated p42/44 MAPK suggests that p42/44 MAPK may play an important role in regulating hepatic IL-6 expression. Our results also suggest that maternal immune activation could have differential effects on various inflammatory mediators in the liver of the offspring.
What problem does this paper attempt to address?